Sirisha L Vavilala
Overview
Explore the profile of Sirisha L Vavilala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gokhale K, Patravale V, Pingale R, Pandey P, Vavilala S
Biomed Mater
. 2024 Jul;
19(5).
PMID: 39025122
The majority of research on nanomaterials has been concentrated on metal nanoparticles since they are easily made and manipulated. Nanomaterials have shown a wide range of applications in biology. Nevertheless,...
2.
Pandey P, Rao L, Shekhar B, Das D, Vavilala S
Chem Biol Interact
. 2024 May;
396:111027.
PMID: 38735452
Antibiotic resistance poses a significant challenge in modern medicine, urging the exploration of innovative approaches to combat bacterial infections. Biofilms, complex bacterial communities encased in a protective matrix, contribute to...
3.
Pandey P, Vavilala S
Cell Biochem Biophys
. 2024 May;
82(2):549-560.
PMID: 38702575
In recent decades, the development of novel antimicrobials has significantly slowed due to the emergence of antimicrobial resistance (AMR), intensifying the global struggle against infectious diseases. Microbial populations worldwide rapidly...
4.
Pandey P, Pradhan S, Meher K, Lopus M, Vavilala S
Biomed Mater
. 2024 Feb;
19(2).
PMID: 38364289
Respiratory tract infections (RTIs) are a common cause of mortality and morbidity in the human population. The overuse of antibiotics to overcome such infections has led to antibiotic resistance. The...
5.
Shaikh S, Patel B, Priyadarsini I, Vavilala S
Int Microbiol
. 2022 Dec;
26(4):693-704.
PMID: 36507979
Aim Of The Study: The rising instances of multidrug-resistant pathogens are rapidly evolving into a global healthcare crisis. Identifying new ways of synthesis of antibiotics is both time-consuming and expensive....
6.
Vishwakarma J, Waghela B, Falcao B, Vavilala S
Appl Biochem Biotechnol
. 2021 Aug;
194(2):671-693.
PMID: 34449042
The growth of respiratory diseases, as witnessed through the SARS and COVID-19 outbreaks, and antimicrobial-resistance together pose a serious threat to humanity. One reason for antimicrobial resistance is formation of...
7.
Patel B, Mishra S, Priyadarsini I, Vavilala S
Biol Chem
. 2021 Mar;
402(7):769-783.
PMID: 33735944
Bacteria are increasingly relying on biofilms to develop resistance to antibiotics thereby resulting in their failure in treating many infections. In spite of continuous research on many synthetic and natural...
8.
Ghodake V, Vishwakarma J, Vavilala S, Patravale V
Int J Pharm
. 2020 Aug;
587:119696.
PMID: 32736020
Cystic fibrosis (CF), an atypical genetic disorder, develops due to mutations in cystic fibrosis transmembrane conductance regulator gene, which consequently leads to infection and inflammation. CF infections are commonly characterized...
9.
Panigrahi G, Rane A, Vavilala S, Choudhary S
J Biochem
. 2019 Aug;
166(6):463-474.
PMID: 31385584
Parkinsonism-linked mutations in alanine and glutamic acid residues of the pre-synaptic protein α-Synuclein (α-Syn) affect specific tertiary interactions essential for stability of the native state and make it prone to...
10.
Choudhary S, Save S, Vavilala S
Sci Rep
. 2018 Apr;
8(1):5692.
PMID: 29632314
α-Synuclein (α-Syn) is an intrinsically disordered presynaptic protein, whose aggregation is critically involved in Parkinson's disease (PD). Many of the currently available drugs for the treatment of PD are not...